"Neuromed - Istituto Neurologico Mediterraneo è un Istituto di Ricovero e Cura a Carattere Scientifico(I.R.C.C.S.) e un centro di rilevanza nazionale e di altissima specializzazione per patologie afferenti alla Neurochirurgia, Neurologia, Riabilitazione(cod.56,75-1 e 75-2) e Chirurgia Vascolare ed Endovascolare. È riconosciuto dal Ministero della Salute e dalla Regione Molise tra i centri che si distinguono per la qualità delle cure e la capacità di trasferire i risultati della ricerca e nellattività clinica quotidiana(ricerca traslazionale). Neuromed è convenzionato con il SSN e al cuore della sua missione cè una forte integrazione tra Cura, Ricerca e Didattica."

During the past decade, IRCCS Neuromed conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 2 clinical trials were completed, i.e. on average, 4.4% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 2 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "IRCCS Neuromed" #1 sponsor was "Neuromed IRCCS" with 44 trials, followed by "Biogen" with 1 trials sponsored, "Centro Cardiologico Monzino" with 1 trials sponsored, "Guerbet" with 1 trials sponsored and "University of Campania "Luigi Vanvitelli"" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "IRCCS Neuromed" #1 collaborator was "IRCCS Multimedica" with 3 trials as a collaborator, "Neuromed IRCCS" with 2 trials as a collaborator, "Clinica Mediterranea" with 1 trials as a collaborator, "Co-investigator: Francesco Pompeo" with 1 trials as a collaborator and "Federico II University" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "IRCCS Neuromed" are "Hypertension" (5 trials), "Multiple Sclerosis" (5 trials), "Parkinson Disease" (5 trials), "Brain Injuries" (2 trials) and "Cancer" (2 trials). Many other conditions were trialed in "IRCCS Neuromed" in a lesser frequency.

Most popular intervention types in "IRCCS Neuromed" are "Other" (10 trials), "Procedure" (7 trials), "Drug" (5 trials), "Behavioral" (4 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "No interventions" (2 trials), "BIIB054" (1 trials), "Blood withdrawal" (1 trials) and "Clinical evaluation of vision and eye tests" (1 trials). Other intervention names were less common.

The vast majority of trials in "IRCCS Neuromed" are 49 trials for "All" genders.

Currently, there are NaN active trials in "IRCCS Neuromed". 3 are not yet recruiting, 20 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in IRCCS Neuromed, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in IRCCS Neuromed, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 10 trials that are defined as “Not Applicable".

IRCCS Neuromed has several departments that took part in Clinical trials: "IRCCS Istituto Neurologico Neuromed; Centro per lo Studio e la Cura della Sclerosi Multipla" - 9 trials, "IRCCS Neuromed; Neurologia I-Centro studio e cura delle demenze e UVA" - 5 trials